Patent · US Active

Use of octenidine dihydrochloride in semisolid preparations

US7846947B2 · kind B2 · utility

0Cited by

3References

7Claims

0Family size

Assignee

Air Liquide Santé (International) · FR

Inventors

Jörg Siebert · Norderstedt, DE
Mona Golombiewski · Lüneburg, DE
Rita Blankenburg · Hamburg, DE
Peter Goroncy-Bermes · Hamburg, DE
Andreas Dettmann · Hamburg, DE
Sabine Behrends · Appen, DE

Key dates

Filing date	Sep 12, 2006
Grant date	Dec 7, 2010
Priority date	—
Expiry date	Sep 12, 2026

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P37/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to the use of octenidine dihydrochloride for manufacturing a semisolid pharmaceutical composition for the treatment of wounds, atopic dermatitides, infected eczemas, dermatomycoses, vaginal infections, acne, herpes and/or for controlling multidrug-resistant pathogens, where the composition comprises from 0.005 to 5% by weight octenidine dihydrochloride, and a corresponding composition.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.